Lindsay J. Bawden
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Immunotherapy and Immune Responses, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor(1994)219 cited
- → CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells(2008)117 cited
- → Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor(2010)83 cited
- → Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors(2021)71 cited
- → BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties(1995)71 cited
- → Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs(2011)69 cited
- → Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation.(1991)66 cited
- → Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA(1999)56 cited
- → A phase I first‐in‐human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies(2013)45 cited
- → Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity(1992)13 cited